ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
39 hedge funds and large institutions have $47.9M invested in Elevation Oncology in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
44% more funds holding
Funds holding: 27 → 39 (+12)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
Holders
39
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$3.95M | |
| 2 | +$3.64M | |
| 3 | +$3.52M | |
| 4 |
O
OrbiMed
New York
|
+$2.28M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$2.28M |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$1.67M | |
| 3 | -$503K | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$284K |
| 5 |
Morgan Stanley
New York
|
-$220K |